Envisioning Future UTI Diagnostics.
| dc.contributor.author | Patel, Robin | |
| dc.contributor.author | Polage, Christopher R | |
| dc.contributor.author | Dien Bard, Jennifer | |
| dc.contributor.author | May, Larissa | |
| dc.contributor.author | Lee, Francesca M | |
| dc.contributor.author | Fabre, Valeria | |
| dc.contributor.author | Hayden, Mary K | |
| dc.contributor.author | Doernberg, Sarah DB | |
| dc.contributor.author | Haake, David A | |
| dc.contributor.author | Trautner, Barbara W | |
| dc.contributor.author | Grigoryan, Larissa | |
| dc.contributor.author | Tsalik, Ephraim L | |
| dc.contributor.author | Hanson, Kimberly E | |
| dc.date.accessioned | 2022-03-01T14:46:18Z | |
| dc.date.available | 2022-03-01T14:46:18Z | |
| dc.date.issued | 2021-08-31 | |
| dc.date.updated | 2022-03-01T14:46:17Z | |
| dc.description.abstract | Urinary tract infections (UTIs) are among the most common bacterial infections in the United States and are a major driver of antibiotic use - both appropriate and inappropriate - across healthcare settings. UTI treatment has become complex due to antibacterial resistance; one quarter of urinary tract isolates of Escherichia coli in the United States in 2017 were resistant to fluoroquinolones and one third to trimethoprimsulfamethoxazole (1), agents with historically predictable activity against E. coli. As a result, more broad-spectrum antibiotics are being used to treat UTIs, contributing to selection of further antibiotic resistance. | |
| dc.identifier | 6360329 | |
| dc.identifier.issn | 1058-4838 | |
| dc.identifier.issn | 1537-6591 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | Oxford University Press (OUP) | |
| dc.relation.ispartof | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | |
| dc.relation.isversionof | 10.1093/cid/ciab749 | |
| dc.subject | urinary tract infection | |
| dc.subject | UTI | |
| dc.subject | laboratory diagnosis | |
| dc.subject | diagnostics | |
| dc.title | Envisioning Future UTI Diagnostics. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Tsalik, Ephraim L|0000-0002-6417-2042 | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Basic Science Departments | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Molecular Genetics and Microbiology | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, Infectious Diseases | |
| pubs.publication-status | Published |
Files
Original bundle
- Name:
- Envisioning Future UTI Diagnostics Final.pdf
- Size:
- 548.15 KB
- Format:
- Adobe Portable Document Format
- Description:
- Accepted version